Clinical trial
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell…
NCT00385996 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00385996 |
|---|---|
| Title | Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer |
| Official title | A Pilot Study of Preoperative Tarceva (Erlotinib) Monotherapy in Patients With Early Stage (I/II) Non-Small Cell Lung Cancer |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | OSI Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-small Cell Lung |
| Intervention type | Drug |
| Interventions | Tarceva (Erlotinib) |
| Enrollment | 22 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Aug 1, 2011 |
| First posted | Oct 11, 2006 |
| Last update posted | Dec 28, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: